Login
Subscribe
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.
arthritis, immunology
B Cell Bosses
Kate Yandell | Feb 1, 2015 | 3 min read
Gut bacteria in mice spur regulatory B cells to differentiate and release an anti-inflammatory cytokine.